Cote Law PLLC | USA | 11 Apr 2022
The Drug Enforcement Administration (DEA) issued a Notice of Proposed Rulemaking (NPRM) seeking to “revoke the exempted prescription product status…
Cote Law PLLC | USA | 18 Nov 2021
On November 19, 2021, the Drug Enforcement Administration (“DEA”) issued a Notice of Proposed Rulemaking (“NPRM”) “to allow the transfer of electronic…
Cote Law PLLC | USA | 16 Nov 2021
On November 17, 2021, the Drug Enforcement Administration (DEA) issued an Advanced Notice of Proposed Rulemaking (the “Notice”) seeking the public’s…
Cote Law PLLC | USA | 17 Mar 2021
The COVID pandemic notwithstanding, the Drug Enforcement Administration (DEA), Department of Justice and other federal and state agencies continue to…
Cote Law PLLC | USA | 26 Jan 2021
The Washington Post reports that the Biden Administration is preparing to pull back recent Health and Human Services (HHS) guidance designed to expand…
Cote Law PLLC | USA | 14 Jan 2021
As I was reviewing the public comments regarding the Drug Enforcement Administration’s (DEA’s) Notice of Proposed Rulemaking (NPRM) providing a…
Cote Law PLLC | USA | 3 Dec 2020
More than four years ago, the Comprehensive Addiction and Recovery Act of 2016 (“CARA”) was signed into law. CARA, among other things, includes…
Cote Law PLLC | USA | 30 Oct 2020
The Drug Enforcement Administration (DEA) published its long-awaited Notice of Proposed Rulemaking (NPRM) regarding suspicious orders of controlled…
Cote Law PLLC | USA | 28 Oct 2020
Pharmacies and pharmacists have always been on the front lines in terms of medication safety and the pandemic has produced a new layer of challenges…
Cote Law PLLC | USA | 25 Oct 2020
Based on information posted on its website, the National Technical Information Service (NTIS) will end its CSA subscription service, effective…